Full Text Full Text (PDF) Correction (v160,p2076) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Chen, Y. Articles by Holzman, P. S. Search for Related Content PubMed Citation Articles by Chen, Y. Articles by Holzman, P. S. Schizophrenia Spectrum Disorders Symptoms/Dimensions Related Article

Effects of Typical, Atypical, and No Antipsychotic Drugs on Visual Contrast Detection in Schizophrenia

OBJECTIVE: Visual contrast detection has been reported in some studies to be normal in schizophrenia patients, but in other studies impairments have been reported. Because contrast detection in the visual processing system is mediated by dopamine, and because the pharmacotherapy of schizophrenia involves blocking dopamine postsynaptic receptor sites, the authors investigated the effects of dopamine-blocking antipsychotic drugs on visual contrast detection in schizophrenia. METHOD: Visual contrast detection thresholds were measured in healthy subjects and schizophrenia patients receiving typical and atypical antipsychotic drugs; a two-alternative, forced-choice psychophysical method was used. Also included were six patients receiving no antipsychotic treatment as well as clinically unaffected first-degree relatives of the schizophrenia patients. RESULTS: Patients receiving atypical antipsychotic drugs showed unimpaired visual contrast detection, those given typical antipsychotic drugs exhibited higher visual contrast detection thresholds, and the unmedicated schizophrenic patients showed visual contrast detection thresholds significantly below those of healthy subjects. CONCLUSIONS: Dopamine modulation via D₂ receptor blockade affects sensory processes in schizophrenia, shifting visual contrast detection from hypersensitivity in the unmedicated state to normal and even to hyposensitive levels. Thus, antipsychotic drug treatment may account for the inconsistent reports concerning visual contrast detection in schizophrenia.

Related Article:

In This Issue
Am J Psychiatry 2003 160: A62. [Full Text] [PDF]

This article has been cited by other articles:

				Y. Chen, D. Norton, D. Ongur, and S. Heckers Inefficient Face Detection in Schizophrenia Schizophr Bull, March 1, 2008; 34(2): 367 - 374. [Abstract] [Full Text] [PDF]

				D. Tadin, J. Kim, M. L. Doop, C. Gibson, J. S. Lappin, R. Blake, and S. Park Weakened center-surround interactions in visual motion processing in schizophrenia. J. Neurosci., November 1, 2006; 26(44): 11403 - 11412. [Abstract] [Full Text] [PDF]

				P. D. Butler, V. Zemon, I. Schechter, A. M. Saperstein, M. J. Hoptman, K. O. Lim, N. Revheim, G. Silipo, and D. C. Javitt Early-Stage Visual Processing and Cortical Amplification Deficits in Schizophrenia Arch Gen Psychiatry, May 1, 2005; 62(5): 495 - 504. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us